Dr. Krogan received an undergraduate degree in chemistry and an MSc in biology from the University of Regina, and a Ph.D. in medical genetics from the University of Toronto. He came to UC San Francisco as a Sandler Fellow in 2006 and started as a faculty member the following year. In 2011, he became an investigator at the Gladstone Institute of Data Science and Biotechnology, and in 2016 he was appointed director of QBI, which is part of the UCSF School of Pharmacy. He has joint UCSF appointments in the School of Medicine’s Department of Cellular and Molecular Pharmacology and the School of Pharmacy’s Department of Bioengineering and Therapeutic Sciences. In 2022, Dr. Krogan was awarded the highest honor in France, the Legion of Honor, which was bestowed for his leadership in forming international research collaboration across academic and industry organizations around the world and for their significant scientific contributions utilizing a novel methodology of identifying the viral modifications of human proteins that fueled SARS-CoV-2 pathology to identify potential treatments against COVID-19.